Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infectionsLuca Mezzadri, Paolo Bonfanti, Paolo Maggi et al.|Journal of Global Antimicrobial Resistance|2024Cited by 4
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics).Sara Tordi, Giuseppe Vittorio De Socio, Elena Ricci et al.|PubMed|2025Cited by 1